BTN3A2 and benign prostatic hyperplasia: Using a comprehensive suite of analytical methods, other studies have identified BTN3A2 and C4A as key genetic contributors to BPH pathogenesis and further delineated the cg14345882-BTN3A2-BPH pathogenic pathway.